New tools enabling data access can help patients choose the most appropriate site of care for their needs, representing a significant change in the care delivery paradigm, according to Vanessa Sammy, MPA, MHSA, senior director of commercial strategy and implementation for Remedy Partners.
New tools enabling data access can help patients choose the most appropriate site of care for their needs, representing a significant change in the care delivery paradigm, according to Vanessa Sammy, MPA, MHSA, senior director of commercial strategy and implementation for Remedy Partners.
Transcript
New partnerships in healthcare are reinventing how care is delivered and how patients enter the health system—what are the benefits to re-engineering the entrance into the system?
Right, it is exciting to be part of the change in delivery of care. You know, when I was young, it was really just a matter of going to the primary care doctor and they would dictate who your referral would be to. There was little to no information to the consumer about where you were going or where the next site was, and largely you could just go to the primary care facility that you had access to. In this new model that we’re moving towards, it’s an exciting time because there’s suddenly data and access that’s helping consumers understand where to go and what site of care is most appropriate to them. So for instance there are data tools out there that are providing members with the ability to know whether they should be selecting one facility over another. We certainly take the initiative in our episodes of care to identify early indicators with members and help them select which facility is best for them at that time.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More